Literature DB >> 7083150

Positive correlation between calmodulin content and hepatoma growth rates.

J W Wei, H P Morris, R A Hickie.   

Abstract

Calmodulin contents of normal rat liver, host liver [bearing hepatoma 5123t.c.(h)], regenerating liver, and Morris hepatomas 7800, 5123t.c.(h), and 7794A were determined by phosphodiesterase assay and by radioimmunoassay. The calmodulin levels determined by both assays were significantly increased in three hepatomas when compared to the corresponding values of normal liver. The order of increase in calmodulin content was as follows: normal liver = host liver less than 7794A (slow growth rate) less than 5123t.c.(h) (intermediate growth rate) less than 7800 (fast growth rate). In regenerating liver (24 hr after partial hepatectomy), the calmodulin content was not different from that of normal liver. In good agreement with the literature, the calmodulin values measured by the phosphodiesterase assay were always lower than those determined by radioimmunoassay. Calcium and magnesium contents were measured by atomic absorption spectrophotometry in acid digests of these tissues. Both cation contents were significantly increased in the three hepatomas studied when compared to the corresponding values of normal liver; the extent of increase for calcium content (120 to 240%) was much greater than that for magnesium (30 to 40%). The order of increase for both cations was as follows: normal liver = host liver less than 5123t.c.(h) less than 7794A less than 7800. Therefore, there does not appear to be any correlation between the cation contents and hepatoma growth rates. In regenerating liver, magnesium content was about 14% higher than that of normal liver. In summary, the results indicate that only the increase of calmodulin appears to correlate positively with the growth rate of these tumors. This correlation suggests that calmodulin may be involved in tumor cell growth regulation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7083150

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

1.  Identification and characterization of a Ca2+-calmodulin-sensitive cyclic nucleotide phosphodiesterase in a human lymphoblastoid cell line.

Authors:  P M Epstein; S Moraski; R Hachisu
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

2.  Metformin blocks migration and invasion of tumour cells by inhibition of matrix metalloproteinase-9 activation through a calcium and protein kinase Calpha-dependent pathway: phorbol-12-myristate-13-acetate-induced/extracellular signal-regulated kinase/activator protein-1.

Authors:  Yong P Hwang; Hye G Jeong
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

3.  Free calcium and calmodulin levels in acinar carcinoma and normal acinar cells of rat pancreas.

Authors:  J L Chien; J R Warren
Journal:  Int J Pancreatol       Date:  1988-03

4.  Calmodulin Binding to Death Receptor 5-mediated Death-Inducing Signaling Complex in Breast Cancer Cells.

Authors:  Romone M Fancy; Harrison Kim; Tong Zhou; Kurt R Zinn; Donald J Buchsbaum; Yuhua Song
Journal:  J Cell Biochem       Date:  2017-04-12       Impact factor: 4.429

5.  Calmodulin antagonist enhances DR5-mediated apoptotic signaling in TRA-8 resistant triple negative breast cancer cells.

Authors:  Romone M Fancy; Harrison Kim; Tiara Napier; Donald J Buchsbaum; Kurt R Zinn; Yuhua Song
Journal:  J Cell Biochem       Date:  2018-04-16       Impact factor: 4.429

6.  The combination of calmodulin antagonists and interferon-gamma induces apoptosis through caspase-dependent and -independent pathways in cholangiocarcinoma cells.

Authors:  Eun-Young Ahn; George Pan; Jae Hwan Oh; Ewan M Tytler; Jay M McDonald
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

7.  Characterization of the Interactions between Calmodulin and Death Receptor 5 in Triple-negative and Estrogen Receptor-positive Breast Cancer Cells: AN INTEGRATED EXPERIMENTAL AND COMPUTATIONAL STUDY.

Authors:  Romone M Fancy; Lingyun Wang; Thomas Schmid; Qinghua Zeng; Hong Wang; Tong Zhou; Donald J Buchsbaum; Yuhua Song
Journal:  J Biol Chem       Date:  2016-04-22       Impact factor: 5.157

8.  Inhibition of human breast cancer colony formation by anticalmodulin agents: trifluoperazine, W-7, and W-13.

Authors:  J W Wei; R A Hickie; D J Klaassen
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

9.  Calmodulin content of rat mammary tissue and isolated cells during pregnancy and lactation.

Authors:  T L Riss; P J Bechtel; C R Baumrucker
Journal:  Biochem J       Date:  1984-05-01       Impact factor: 3.857

10.  Pig-skin epidermal calmodulin: effects of antagonists of calmodulin on DNA synthesis of pig-skin epidermis.

Authors:  H Iizuka; Y Hashimoto; M Hirokawa; S Matsuo; T Mizumoto; A Ohkawara
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.